Abstract
Bioactive proteins and peptides are recognised as novel therapeutic molecules with varying biological properties for potential medical applications. Development of protein and peptidebased therapeutic products for human use is growing steadily as they continue to receive an increasing rate of approval by the United States Food and Drugs Administration (US FDA). In this short review, we describe the current status and methodologies involved in the synthesis of protein and peptide biopharmaceuticals with an emphasis on the drivers and restrains to their exploitation in the therapeutic products sector.
Keywords: Bioactive peptides, bioactive proteins, therapeutics, biopharmaceuticals, bioprocessing.
Protein & Peptide Letters
Title:Protein and Peptide Biopharmaceuticals: An Overview
Volume: 24 Issue: 2
Author(s): Dominic Agyei, Ishtiaq Ahmed, Zain Akram, Hafiz M. N. Iqbal and Michael K. Danquah
Affiliation:
Keywords: Bioactive peptides, bioactive proteins, therapeutics, biopharmaceuticals, bioprocessing.
Abstract: Bioactive proteins and peptides are recognised as novel therapeutic molecules with varying biological properties for potential medical applications. Development of protein and peptidebased therapeutic products for human use is growing steadily as they continue to receive an increasing rate of approval by the United States Food and Drugs Administration (US FDA). In this short review, we describe the current status and methodologies involved in the synthesis of protein and peptide biopharmaceuticals with an emphasis on the drivers and restrains to their exploitation in the therapeutic products sector.
Export Options
About this article
Cite this article as:
Agyei Dominic, Ahmed Ishtiaq, Akram Zain, Iqbal M. N. Hafiz and Danquah K. Michael, Protein and Peptide Biopharmaceuticals: An Overview, Protein & Peptide Letters 2017; 24 (2) . https://dx.doi.org/10.2174/0929866523666161222150444
DOI https://dx.doi.org/10.2174/0929866523666161222150444 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Emerging Therapies for Diabetic Neuropathy: A Clinical Overview
Current Diabetes Reviews Complications Associated with Recombinant Tissue Plasminogen Activator Therapy for Acute Ischaemic Stroke
CNS & Neurological Disorders - Drug Targets The Large and Growing Burden of Stroke
Current Drug Targets Vitamin D and Cardio-Metabolic Risk Factors in Overweight Adults: An Overview of the Evidence
Current Pharmaceutical Design Can Targeting the Incretin Pathway Dampen RAGE-Mediated Events in Diabetic Nephropathy?
Current Drug Targets Endothelial Therapy of Atherosclerosis and its Risk Factors
Current Vascular Pharmacology The Vascular Component of Alzheimer`s Disease
Current Neurovascular Research Imidazole: An Essential Edifice for the Identification of New Lead Compounds and Drug Development
Mini-Reviews in Medicinal Chemistry Endothelin-1: The Yin and Yang on Vascular Function
Current Medicinal Chemistry Antiangiogenic Drugs in the Treatment of Advanced Epithelial Ovarian Cancer
Anti-Cancer Agents in Medicinal Chemistry Editorial: Alteration of Redox Equilibrium, Inflammation and Progression of Disease
Current Medicinal Chemistry The Importance of Lost Minerals in Heart Failure
Cardiovascular & Hematological Agents in Medicinal Chemistry Genomic and Epigenetic Complexity of the FOXF1 Locus in 16q24.1: Implications for Development and Disease
Current Genomics Role of Tissue Renin-angiotensin System and the Chymase/angiotensin-( 1-12) Axis in the Pathogenesis of Diabetic Retinopathy
Current Medicinal Chemistry Bleeding, Vertebral Fractures and Vascular Calcifications in Patients Treated with Warfarin: Hope for Lower Risks with Alternative Therapies
Current Vascular Pharmacology Novel Approaches to the Treatment of Obesity and Type 2 Diabetes Mellitus: Bioactive Leptin-Related Synthetic Peptide Analogs
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Seaweed Proteins as a Source of Bioactive Peptides
Current Pharmaceutical Design Human Saphenous Vein and Coronary Bypass Surgery: Scanning Electron Microscopy of Conventional and ‘No-Touch’ Vein Grafts
Vascular Disease Prevention (Discontinued) Using Metformin in Pregnancy for Different Indications: Are We Any Wiser now?
Applied Clinical Research, Clinical Trials and Regulatory Affairs Mutual Modulation of Femarelle and Vitamin D Analog Activities in Human Derived Female Cultured Osteoblasts
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued)